US recommends ‘pause’ to Johnson & Johnson jab rollout over blood clot fears

US

The US Food and Drug Administration has recommended a “pause” to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.

Officials say they are looking into six reported cases “of a rare & severe type of blood clot in individuals after receiving the vaccine”.

“Right now, these adverse events appear to be extremely rare,” the FDA said in a statement on Twitter.

It said until the cases had been assessed for their potential significance, “we are recommending this pause”.

“This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot,” it added.

Articles You May Like

Tesla Model 3 prototype spotted ahead of rumored design refresh
Jack Dorsey’s Block backs bitcoin mining company that wants to bring 25-cent electricity to rural Africa
The 7 must-watch fights at UFC 282
Eddie Jones sacked as England head coach
Jake Tapper: Trump focused on rewarding loyalists